Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
出版年份 2020 全文链接
标题
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume 37, Issue 6, Pages 2956-2975
出版商
Springer Science and Business Media LLC
发表日期
2020-04-25
DOI
10.1007/s12325-020-01311-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD
- (2019) Luigino Calzetta et al. CHEST
- Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
- (2019) Michael Bogart et al. International Journal of Chronic Obstructive Pulmonary Disease
- Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
- (2019) Dave Singh et al. International Journal of Chronic Obstructive Pulmonary Disease
- Triple versus dual inhaler therapy in moderate‐to‐severe COPD: A systematic review and meta‐analysis of randomized controlled trials
- (2019) Yazan Zayed et al. Clinical Respiratory Journal
- A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
- (2019) Klaus F. Rabe et al. RESPIRATORY MEDICINE
- Long-term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple-Dummy Clinical Trial
- (2018) Kenneth R Chapman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
- (2018) Mario Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Sensitivity of treatment recommendations to bias in network meta-analysis
- (2017) David M. Phillippo et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
- Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
- (2017) Jørgen Vestbo et al. LANCET
- Optimizing drug delivery in COPD: The role of inhaler devices
- (2017) Paola Rogliani et al. RESPIRATORY MEDICINE
- Use of network meta-analysis in clinical guidelines
- (2016) Steve Kanters et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis
- (2016) Max Schlueter et al. Therapeutic Advances in Respiratory Disease
- Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers
- (2016) Andrew P. Yu et al. JOURNAL OF MEDICAL ECONOMICS
- Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
- (2015) Wendy P. Battisti et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies
- (2015) Thomas M. Siler et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners
- (2015) Mathieu Molimard et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
- (2015) Nicola Scichilone et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies
- (2015) Thomas M. Siler et al. RESPIRATORY MEDICINE
- Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia
- (2015) Sang-Do Lee et al. RESPIROLOGY
- Network Meta-Analysis: Development of a Three-Level Hierarchical Modeling Approach Incorporating Dose-Related Constraints
- (2015) Rhiannon K. Owen et al. VALUE IN HEALTH
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
- (2014) Helgo Magnussen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: A randomized controlled study
- (2011) Ki Suck Jung et al. RESPIRATORY MEDICINE
- Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
- (2011) Nicola A. Hanania et al. RESPIRATORY MEDICINE
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
- Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
- (2009) Tobias Welte et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now